2,985 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 933 increasing their positions, 1,460 reducing their positions, and 245 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less capital invested

Capital invested by funds: $109B → $100B (-$8.71B)

15% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $3.87B

36% less repeat investments, than reductions

Existing positions increased: 933 | Existing positions reduced: 1,460

Holders
2,985
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.28B
Puts
$3.87B
Net Calls
Net Calls Change

Top Sellers

1 -$644M
2 -$337M
3 -$293M
4
JP Morgan Chase
JP Morgan Chase
New York
-$285M
5
Barclays
Barclays
United Kingdom
-$277M
Name Holding Trade Value Shares
Change
Change in
Stake
1901
$514K
1902
$514K
1903
$513K
1904
$512K
1905
$511K
1906
$510K
1907
$510K
1908
$510K
1909
$509K
1910
$509K
1911
$509K
1912
$508K
1913
$508K
1914
$507K
1915
$507K
1916
$506K
1917
$505K
1918
$504K
1919
$502K
1920
$501K
1921
$499K
1922
$498K
1923
$498K
1924
$497K
1925
$496K